Benzinga | Aug 4, 2020 07:22AM EDT

FDA Issues Emergency Use Authorization For Impella Heart Pumps To Provide Unloading Therapy To COVID-19 Patients; Impella Is Manufactured By Abiomed

The United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients whoThe United States Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella heart pumps to provide left ventricular unloading and support to COVID-19 patients who are undergoing ECMO treatment and develop pulmonary edema or myocarditis. Impella is manufactured by Abiomed (NASDAQ:ABMD).

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200804005379/en/